Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. Fraschke
Cost-Effectiveness Analysis of Rivaroxaban in Secondary Prevention of ACS in Sweden
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Pcv76 - Cost-Effectiveness Analysis of Rivaroxaban in the Secondary Prevention of Acute Coronary Syndromes in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness Analysis of Bisphosphonates for Secondary Prevention of Hip Fracture in Taiwan
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
845 Cost-Effectiveness Analysis in Fire Prevention
Injury Prevention
Environmental
Public Health
Occupational Health
Pcv40 - Budget Impact Analysis of Rivaroxaban in the Secondary Prevention of Acute Coronary Syndromes in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Cost of Illness Attributable to Diabetic Foot and Cost-Effectiveness of Secondary Prevention in Peru
BMC Health Services Research
Health Policy
Cost-Effectiveness of Rivaroxaban for the Treatment of Pulmonary Embolism in Canada
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness of Rivaroxaban for the Prevention of Stroke in Patients With Non-Valvular Atrial Fibrillation – A Multinational Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcv79 - Real-World Cost-Effectiveness of Rivaroxaban Compared With Vitamin K Antagonists in the Context of Stroke Prevention in Atrial Fibrillation in France
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Intact Cost-Effectiveness of Screening for Abdominal Aortic Aneurysms in Sweden
European Journal of Vascular and Endovascular Surgery
Surgery
Cardiovascular Medicine
Cardiology
